概述
产品名称
p53 (acetyl K382) Recombinant Rabbit Monoclonal Antibody [SD0801]
抗体类型
Recombinant Rabbit monoclonal Antibody
免疫原
Synthetic peptide within Human p53 aa 350 to the C-terminus (acetyl K382).
种属反应性
Human, Mouse
验证应用
WB, IF-Cell, IHC-P
分子量
Predicted band size: 53 kDa
阳性对照
NIH/3T3 treated with 400nM TSA and 0.5μM doxorubicin for 24 hours whole cell lysate, HeLa treated with 400nM TSA and 0.5μM doxorubicin for 24 hours whole cell lysate, human breast carcinoma tissue.
偶联
unconjugated
克隆号
SD0801
RRID
产品特性
形态
Liquid
浓度
1ug/ul
存放说明
Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
存储缓冲液
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
亚型
IgG
纯化方式
Protein A affinity purified.
应用稀释度
-
WB
-
1:1,000-1:2,000
-
IF-Cell
-
1:50-1:100
-
IHC-P
-
1:50-1:100
发表文章中的应用
WB | 查看 2 篇文献如下 |
发表文章中的种属
Mouse | 查看 2 篇文献如下 |
Human | 查看 1 篇文献如下 |
靶点
功能
Antigen NY-CO-13 antibody BCC7 antibody Cellular tumor antigen p53 antibody FLJ92943 antibody LFS1 antibody Mutant tumor protein 53 antibody p53 antibody p53 tumor suppressor antibody P53_HUMAN antibody Phosphoprotein p53 antibody Tp53 antibody Transformation related protein 53 antibody TRP53 antibody Tumor protein 53 antibody Tumor protein p53 antibody Tumor suppressor p53 antibody
背景文献
1. Kim TH et al. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts. Biochim Biophys Acta 1850:401-10 (2015).
2. Allison SJ et al. Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways. Oncogenesis 3:e102 (2014).
序列相似性
Belongs to the p53 family.
组织特异性
Ubiquitous. Isoforms are expressed in a wide range of normal tissues but in a tissue-dependent manner. Isoform 2 is expressed in most normal tissues but is not detected in brain, lung, prostate, muscle, fetal brain, spinal cord and fetal liver. Isoform 3 is expressed in most normal tissues but is not detected in lung, spleen, testis, fetal brain, spinal cord and fetal liver. Isoform 7 is expressed in most normal tissues but is not detected in prostate, uterus, skeletal muscle and breast. Isoform 8 is detected only in colon, bone marrow, testis, fetal brain and intestine. Isoform 9 is expressed in most normal tissues but is not detected in brain, heart, lung, fetal liver, salivary gland, breast or intestine.
翻译后修饰
Acetylated. Acetylation of Lys-382 by CREBBP enhances transcriptional activity. Deacetylation of Lys-382 by SIRT1 impairs its ability to induce proapoptotic program and modulate cell senescence. Deacetylation by SIRT2 impairs its ability to induce transcription activation in a AKT-dependent manner.; Phosphorylation on Ser residues mediates transcriptional activation. Phosphorylated by HIPK1 (By similarity). Phosphorylation at Ser-9 by HIPK4 increases repression activity on BIRC5 promoter. Phosphorylated on Thr-18 by VRK1. Phosphorylated on Ser-20 by CHEK2 in response to DNA damage, which prevents ubiquitination by MDM2. Phosphorylated on Ser-20 by PLK3 in response to reactive oxygen species (ROS), promoting p53/TP53-mediated apoptosis. Phosphorylated on Thr-55 by TAF1, which promotes MDM2-mediated degradation. Phosphorylated on Ser-33 by CDK7 in a CAK complex in response to DNA damage. Phosphorylated on Ser-46 by HIPK2 upon UV irradiation. Phosphorylation on Ser-46 is required for acetylation by CREBBP. Phosphorylated on Ser-392 following UV but not gamma irradiation. Phosphorylated on Ser-15 upon ultraviolet irradiation; which is enhanced by interaction with BANP. Phosphorylated by NUAK1 at Ser-15 and Ser-392; was initially thought to be mediated by STK11/LKB1 but it was later shown that it is indirect and that STK11/LKB1-dependent phosphorylation is probably mediated by downstream NUAK1. It is unclear whether AMP directly mediates phosphorylation at Ser-15. Phosphorylated on Thr-18 by isoform 1 and isoform 2 of VRK2. Phosphorylation on Thr-18 by isoform 2 of VRK2 results in a reduction in ubiquitination by MDM2 and an increase in acetylation by EP300. Stabilized by CDK5-mediated phosphorylation in response to genotoxic and oxidative stresses at Ser-15, Ser-33 and Ser-46, leading to accumulation of p53/TP53, particularly in the nucleus, thus inducing the transactivation of p53/TP53 target genes. Phosphorylated by DYRK2 at Ser-46 in response to genotoxic stress. Phosphorylated at Ser-315 and Ser-392 by CDK2 in response to DNA-damage. Phosphorylation at Ser-15 is required for interaction with DDX3X and gamma-tubulin.; Dephosphorylated by PP2A-PPP2R5C holoenzyme at Thr-55. SV40 small T antigen inhibits the dephosphorylation by the AC form of PP2A.; May be O-glycosylated in the C-terminal basic region. Studied in EB-1 cell line.; Ubiquitinated by MDM2 and SYVN1, which leads to proteasomal degradation. Ubiquitinated by RFWD3, which works in cooperation with MDM2 and may catalyze the formation of short polyubiquitin chains on p53/TP53 that are not targeted to the proteasome. Ubiquitinated by MKRN1 at Lys-291 and Lys-292, which leads to proteasomal degradation. Deubiquitinated by USP10, leading to its stabilization. Ubiquitinated by TRIM24, RFFL, RNF34 and RNF125, which leads to proteasomal degradation. Ubiquitination by TOPORS induces degradation. Deubiquitination by USP7, leading to stabilization. Isoform 4 is monoubiquitinated in an MDM2-independent manner. Ubiquitinated by COP1, which leads to proteasomal degradation. Ubiquitination and subsequent proteasomal degradation is negatively regulated by CCAR2. Polyubiquitinated by C10orf90/FATS, polyubiquitination is 'Lys-48'-linkage independent and non-proteolytic, leading to TP53 stabilization (By similarity).; Monomethylated at Lys-372 by SETD7, leading to stabilization and increased transcriptional activation. Monomethylated at Lys-370 by SMYD2, leading to decreased DNA-binding activity and subsequent transcriptional regulation activity. Lys-372 monomethylation prevents interaction with SMYD2 and subsequent monomethylation at Lys-370. Dimethylated at Lys-373 by EHMT1 and EHMT2. Monomethylated at Lys-382 by KMT5A, promoting interaction with L3MBTL1 and leading to repress transcriptional activity. Dimethylation at Lys-370 and Lys-382 diminishes p53 ubiquitination, through stabilizing association with the methyl reader PHF20. Demethylation of dimethylated Lys-370 by KDM1A prevents interaction with TP53BP1 and represses TP53-mediated transcriptional activation. Monomethylated at Arg-333 and dimethylated at Arg-335 and Arg-337 by PRMT5; methylation is increased after DNA damage and might possibly affect TP53 target gene specificity.; Sumoylated with SUMO1. Sumoylated at Lys-386 by UBC9.
亚细胞定位
Cytoplasm, Nucleus, Endoplasmic reticulum, Mitochondrion matrix.
别名
Antigen NY-CO-13 antibody
BCC7 antibody
Cellular tumor antigen p53 antibody
FLJ92943 antibody
LFS1 antibody
Mutant tumor protein 53 antibody
p53 antibody
p53 tumor suppressor antibody
P53_HUMAN antibody
Phosphoprotein p53 antibody
展开Antigen NY-CO-13 antibody
BCC7 antibody
Cellular tumor antigen p53 antibody
FLJ92943 antibody
LFS1 antibody
Mutant tumor protein 53 antibody
p53 antibody
p53 tumor suppressor antibody
P53_HUMAN antibody
Phosphoprotein p53 antibody
Tp53 antibody
Transformation related protein 53 antibody
TRP53 antibody
Tumor protein 53 antibody
Tumor protein p53 antibody
Tumor suppressor p53 antibody
折叠图片
-
☑ Cell treatment (CT)
Western blot analysis of p53 (acetyl K382) on different lysates with Rabbit anti-p53 (acetyl K382) antibody (ET1612-71) at 1/1,000 dilution.
Lane 1: NIH/3T3 treated with 400nM TSA and 0.5μM doxorubicin for 24 hours whole cell lysate
Lane 2: NIH/3T3 whole cell lysate
Lane 3: HeLa treated with 400nM TSA and 0.5μM doxorubicin for 24 hours whole cell lysate
Lane 4: HeLa whole cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 53 kDa
Observed band size: 53 kDa
Exposure time: 3 minutes;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1612-71) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/100,000 dilution was used for 1 hour at room temperature. -
☑ Cell treatment (CT)
Immunocytochemistry analysis of HeLa cells untreated / treated with 400nM TSA and 0.5µM doxorubicin for 24 hours labeling p53 (acetyl K382) with Rabbit anti-p53 (acetyl K382) antibody (ET1612-71) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-p53 (acetyl K382) antibody (ET1612-71) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
☑ Cell treatment (CT)
Immunocytochemistry analysis of NIH/3T3 cells untreated / treated with 400nM TSA and 0.5µM doxorubicin for 24 hours labeling p53 (acetyl K382) with Rabbit anti-p53 (acetyl K382) antibody (ET1612-71) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-p53 (acetyl K382) antibody (ET1612-71) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using anti-p53 (acetyl K382) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1612-71, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
请注意: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
引文
-
p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis
Author:
PMID: 37236026
应用: WB
反应种属: Mouse
发表时间: 2023 Aug
-
Citation
-
Choline-induced SLC5A7 impairs colorectal cancer growth by stabilizing p53 protein
Author:
PMID: 34562520
应用: WB
反应种属: Mouse,Human
发表时间: 2022 Jan
-
Citation
同靶点 & 同通路的产品
p53 Rabbit Polyclonal Antibody
Application: WB,IF-Cell
Reactivity: Human
Conjugate: unconjugated
Phospho-p53 (T55) Recombinant Rabbit Monoclonal Antibody [ST0439]
Application: WB,IHC-P
Reactivity: Human
Conjugate: unconjugated
p53 Mouse Monoclonal Antibody [6B5]
Application: WB
Reactivity: Human
Conjugate: unconjugated
p53 Recombinant Mouse Monoclonal Antibody [6B5-R]
Application: WB,IF-Cell
Reactivity: Human,Mouse,Monkey
Conjugate: unconjugated
Phospho-p53 (S15) Recombinant Rabbit Monoclonal Antibody [PSH01-98]
Application: WB,IF-Cell
Reactivity: Human
Conjugate: unconjugated
p53 Recombinant Rabbit Monoclonal Antibody [JB42-26]
Application: WB,IHC-P,FC,IP,IF-Cell,IF-Tissue
Reactivity: Human
Conjugate: unconjugated
p53 Mouse Monoclonal Antibody [7-5]
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
p53 (acetyl K382) Recombinant Rabbit Monoclonal Antibody [PSH06-88]
Application: WB,IF-Cell
Reactivity: Human
Conjugate: unconjugated
p53 Mouse Monoclonal Antibody [6B2]
Application: WB,IF-Cell
Reactivity: Human,Mouse
Conjugate: unconjugated
Phospho-p53 (S392) Recombinant Rabbit Monoclonal Antibody [SI17-04]
Application: WB,IHC-P,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Phospho-p53 (S376) Recombinant Rabbit Monoclonal Antibody [ST0440]
Application: WB
Reactivity: Human,Mouse
Conjugate: unconjugated
p53 Recombinant Mouse Monoclonal Antibody [6B2-R]
Application: WB,IF-Cell
Reactivity: Human,Monkey
Conjugate: unconjugated
Phospho-p53 (S33) Recombinant Rabbit Monoclonal Antibody [JE41-97]
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
p53 (acetyl K382) Recombinant Rabbit Monoclonal Antibody [PSH06-87]
Application: WB,IF-Cell
Reactivity: Human,Mouse
Conjugate: unconjugated
p53 Recombinant Rabbit Monoclonal Antibody [SY010-6]
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human
Conjugate: unconjugated
Phospho-p53 (S20) Recombinant Rabbit Monoclonal Antibody [PSH06-86]
Application: WB
Reactivity: Human
Conjugate: unconjugated
p53 (acetyl K370) Recombinant Rabbit Monoclonal Antibody [SR40-09]
Application: WB,IF-Cell,IF-Tissue,IP,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
p53 Recombinant Rabbit Monoclonal Antibody [PD01-32]
Application: IHC-P
Reactivity: Human
Conjugate: unconjugated
p53 Mouse Monoclonal Antibody [C8-A11]
Application: WB,IF-Cell,IHC-P
Reactivity: Human
Conjugate: unconjugated
p53 Recombinant Rabbit Monoclonal Antibody [SA39-07]
Application: WB,IF-Cell,ChIP
Reactivity: Human
Conjugate: unconjugated
